Source: British Journal of Pharmacology. Unidades: FMRP, FORP
Subjects: FÁRMACOS (SISTEMA NERVOSO CENTRAL), DOENÇA DE PARKINSON, ASTRÓCITOS, INFLAMAÇÃO, ESPÉCIES REATIVAS DE OXIGÊNIO
ABNT
BORTOLANZA, Mariza et al. Doxycycline and its derivative, COL‐3, decrease dyskinesia induced by L-DOPA in hemiparkinsonian rats. British Journal of Pharmacology, v. 178, n. 13, p. 2595-2616, 2021Tradução . . Disponível em: https://doi.org/10.1111/bph.15439. Acesso em: 05 nov. 2024.APA
Bortolanza, M., Nascimento, G. C. do, Raisman‐Vozari, R., & Del Bel, E. A. (2021). Doxycycline and its derivative, COL‐3, decrease dyskinesia induced by L-DOPA in hemiparkinsonian rats. British Journal of Pharmacology, 178( 13), 2595-2616. doi:10.1111/bph.15439NLM
Bortolanza M, Nascimento GC do, Raisman‐Vozari R, Del Bel EA. Doxycycline and its derivative, COL‐3, decrease dyskinesia induced by L-DOPA in hemiparkinsonian rats [Internet]. British Journal of Pharmacology. 2021 ; 178( 13): 2595-2616.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1111/bph.15439Vancouver
Bortolanza M, Nascimento GC do, Raisman‐Vozari R, Del Bel EA. Doxycycline and its derivative, COL‐3, decrease dyskinesia induced by L-DOPA in hemiparkinsonian rats [Internet]. British Journal of Pharmacology. 2021 ; 178( 13): 2595-2616.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1111/bph.15439